Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: ER/PR(+), Her2(-) Breast Cancer
Sponsor: Pfizer